stockrowNeurocrine Biosciences, Inc.
NBIX Healthcare Drug Manufacturers Specialty & Generic
Neurocrine Biosciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 21.4% from fiscal 2024.
- Revenue
- +41.2%
- EPS
- −3.67%
- Free cash flow
- +79.0%
Quarter to September 2026, against a year earlier
Follow NBIX
Alert me
Neurocrine Biosciences, Inc. (NBIX) Operating margin
Neurocrine Biosciences, Inc.'s operating margin over the twelve months to 30 September 2026 was 24.0%, up 2.3 percentage points from fiscal 2025 (21.6%). Over the past ten years it has ranged from −982.5% (fiscal 2016) to 24.2% (fiscal 2024); the current reading is higher than 91% of that period. That is above the Drug Manufacturers Specialty & Generic industry median of 0.00% and above the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | 21.6% | (2.58) |
| FY2024 | 24.2% | 10.92 |
| FY2023 | 13.3% | (3.43) |
| FY2022 | 16.7% | 7.69 |
| FY2021 | 9.04% | (6.54) |
| FY2020 | 15.6% | 6.41 |
| FY2019 | 9.17% | 1.01 |
| FY2018 | 8.16% | 89.43 |
| FY2017 | −81.3% | 901.21 |
| FY2016 | −982.5% | (505.97) |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Sep 2026 | 29.5% | 13.71 |
| Jun 2026 | 15.8% | (7.94) |
| Mar 2026 | 23.7% | (2.44) |
| Dec 2025 | 26.2% | (3.89) |
| 43 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| UTHR United Therapeutics Corporation compare | 41.5% |
| ZTS Zoetis Inc. compare | 37.1% |
| NBIX Neurocrine Biosciences, Inc. | 24.0% |
| HLN Haleon PLC Sponsored ADR compare | 17.9% |
| KNSA Kiniksa Pharmaceuticals International, plc compare | 13.8% |
| RDY Dr. Reddy's Laboratories Ltd compare | 9.20% |
| ALKS Alkermes plc compare | 3.66% |
| ELAN Elanco Animal Health Incorporated compare | 1.61% |
| VTRS Viatris Inc. compare | −0.03% |
| Drug Manufacturers Specialty & Generic industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on NBIX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement